Avanos Medical, Inc. (AVNS) Insider Trading Activity

NYSE$24.98
Market Cap
$1.17B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
176 of 869
Rank in Industry
24 of 112

AVNS Insider Trading Activity

AVNS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$659,300
1
50
Sells
$165,014
1
50

Related Transactions

BLACKFORD GARYdirector
1
$659,300
0
$0
$659,300
Holbrook KerrSVP, Chief Commercial Officer
0
$0
1
$165,014
$-165,014

About Avanos Medical, Inc.

Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.

Insider Activity of Avanos Medical, Inc.

Over the last 12 months, insiders at Avanos Medical, Inc. have bought $659,300 and sold $165,014 worth of Avanos Medical, Inc. stock.

On average, over the past 5 years, insiders at Avanos Medical, Inc. have bought $275,789 and sold $141,591 worth of stock each year.

Highest buying activity among insiders over the last 12 months: BLACKFORD GARY (director) — $659,300.

The last purchase of 60,000 shares for transaction amount of $659,300 was made by BLACKFORD GARY (director) on 2025‑08‑13.

List of Insider Buy and Sell Transactions, Avanos Medical, Inc.

2025-11-18SaleHolbrook KerrSVP, Chief Commercial Officer
15,000
0.0316%
$11.00
$165,014
+22.95%
2025-08-13PurchaseBLACKFORD GARYdirector
60,000
0.1322%
$10.99
$659,300
+14.88%
2025-03-06SaleHolbrook KerrSVP, Chief Commercial Officer
7,000
0.0153%
$15.25
$106,778
-20.49%
2024-03-14SaleGreiner MichaelSVP - Chief Financial Officer
8,000
0.0169%
$19.12
$152,980
+2.85%
2024-03-11PurchaseShimer Julie Anndirector
500
0.0011%
$19.85
$9,925
-1.01%
2021-09-15PurchaseOLEARY PATRICK Jdirector
5,000
0.0103%
$31.63
$158,143
-2.60%
2020-05-08PurchaseBLACKFORD GARYdirector
10,000
0.0214%
$28.75
$287,500
+43.54%
2019-05-30PurchaseWoody Joseph FralinChief Executive Officer
7,000
0.0074%
$19.98
$139,825
-15.72%
2018-11-28PurchaseWoody Joseph FralinChief Executive Officer
7,000
0.0141%
$43.35
$303,450
-6.93%
2018-11-27PurchaseVoskuil Steven ESVP, Chief Financial Officer
4,000
0.0042%
$21.87
$87,470
-2.90%
2018-11-19PurchaseWesley John WSVP, General Counsel
2,000
0.0043%
$47.48
$94,960
-9.68%
2015-09-04PurchaseABERNATHY ROBERT EChairman and CEO
20,000
0.0431%
$31.06
$621,200
+0.10%
2015-09-01PurchaseVoskuil Steven ESVP, Chief Financial Officer
2,000
0.0043%
$30.00
$60,000
+3.03%
Total: 13
*Gray background shows transactions not older than one year

Insider Historical Profitability

0.87%
BLACKFORD GARYdirector
91593
0.1956%
$2.29M20
+43.54%
Holbrook KerrSVP, Chief Commercial Officer
83860
0.1791%
$2.09M02
Greiner MichaelSVP - Chief Financial Officer
151495
0.3235%
$3.78M01
ABERNATHY ROBERT EChairman and CEO
80043
0.1709%
$2M10
+0.1%
Shimer Julie Anndirector
50090
0.107%
$1.25M10
<0.0001%
OLEARY PATRICK Jdirector
33900
0.0724%
$846,822.0010
<0.0001%
Woody Joseph FralinChief Executive Officer
28556
0.061%
$713,328.8820
<0.0001%
Voskuil Steven ESVP, Chief Financial Officer
22238
0.0475%
$555,505.2420
+0.07%
Wesley John WSVP, General Counsel
7502
0.016%
$187,399.9610
<0.0001%
*Gray background shows insiders who have made transactions during last year

AVNS Institutional Investors: Active Positions

Increased Positions119+35.95%4M+9.89%
Decreased Positions131-39.58%4M-9.84%
New Positions36New962,764New
Sold Out Positions44Sold Out1MSold Out
Total Postitions319-3.63%45M+0.05%

AVNS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$76,402.0014.86%6.83M+4,457+0.07%2025-09-30
T. Rowe Price Investment Management, Inc.$52,697.0010.25%4.71M+716,976+17.94%2025-09-30
Vanguard Group Inc$38,294.007.45%3.43M-1M-23.29%2025-09-30
Armistice Capital, Llc$27,950.005.44%2.5M+464,000+22.79%2025-09-30
Dimensional Fund Advisors Lp$26,302.005.11%2.35M-225,430-8.74%2025-09-30
Brown Advisory Inc$24,895.004.84%2.23M+417,921+23.1%2025-09-30
State Street Corp$21,256.004.13%1.9M-16,260-0.85%2025-09-30
D. E. Shaw & Co., Inc.$14,523.002.82%1.3M+107,121+8.99%2025-09-30
Geode Capital Management, Llc$11,935.002.32%1.07M-6,525-0.61%2025-09-30
Aqr Capital Management Llc$10,220.001.99%914,175+354,123+63.23%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.